|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income (loss) from continued operations | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Loss (gain) from change in fair value of derivatives | |||||
| Change in funds in respect of employee rights upon retirement | |||||
| Net change in operating right of use asset and operating lease liability | |||||
| Lease modification | |||||
| Noncash financial expenses (income) | |||||
| Decrease in restructuring plan provision | |||||
| Change in allowance for credit losses | |||||
| Share in results of affiliated companies | |||||
| Share based compensation | |||||
| Liability in respect of employee rights upon retirement | |||||
| Impairment of fixed assets | |||||
| Capital gains from sale of property, plant and equipment | |||||
| Deferred income taxes, net | |||||
| Government loan forgiveness | |||||
| Changes in operating assets and liabilities: | |||||
| increase in trade accounts receivable | |||||
| Decrease (increase) in other current assets and prepaid expenses | |||||
| increase in inventory | |||||
| Increase (decrease) in trade accounts payable | |||||
| Increase (decrease) in accrued expenses and other | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchase of property, plant and equipment | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Repayments of long-term loans | |||||
| Net change in short term loans | |||||
| Proceeds from long-term loans received | |||||
| Proceeds from issuance of ordinary shares and exercise of underwriters’ option | |||||
| Issuance costs of ordinary shares and exercise of the underwriters' option | |||||
| Proceeds from exercise of options | |||||
| Net cash provided by financing activities | |||||
| Net cash provided by operating activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Supplementary information on investing and financing activities not involving cash flows: | |||||
| Purchase of property, plant and equipment on credit | |||||
| Additions of operating lease right-of-use assets and operating lease liabilities | |||||
| Reclassification of inventory to property, plant and equipment | |||||
| Capital contribution to equity method investee | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes received (paid), net | |||||
Loading...